Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yasuda

Showing results (561-570 of 736) with videos related to

Pageof 74
Sort By:
Journal of Musculoskeletal & Neuronal Interactions|December 1, 2010
Musculoskeletal symptoms and neurological investigations in adrenocortical insufficiency: a case report and literature reviewH Kinoshita, S Mizutani, K Sei, et al.
Journal of Neurochemistry|March 31, 1999
Developmental neurotoxicity of phenytoin on granule cells and Purkinje cells in mouse cerebellumH Ohmori, H Ogura, M Yasuda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 29, 1999
[The current status of molecular detection of micrometastatic prostate cancer cells]T Deguchi, M Yang, M Yasuda, et al.
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1994
[Assessment of osteoporosis in the local population by means of a portable dual energy X-ray absorptiometry unit]M Yasuda, T Kurabayashi, T Yahata, et al.
Archives of Neurology|January 29, 1999
A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2M Yasuda, K Maeda, M Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Two novel oleanolic acid saponins having a sialyl Lewis X mimetic structure from Achyranthes fauriei rootY Ida, Y Satoh, M Katsumata, et al.
Nihon Sanka Fujinka Gakkai Zasshi|July 1, 1985
[A study on factors influencing survival in stage I ovarian cancer]M Yasuda, Y Nakabayashi, S Isonishi, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 1, 1988
[A case report of a family with serum cholinesterase deficiency]O Ikami, M Hamada, T Aoki, et al.
Clinical and Experimental Immunology|July 25, 2020
Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot studyA Uzawa, Y Kojima, Y Ozawa, et al.
The American Journal of Cardiology|November 15, 1986
Effect of exercise on circulating atrial natriuretic polypeptide in valvular heart diseaseT Nishikimi, M Kohno, T Matsuura, et al.
Pageof 74

Showing results (561-570 of 736) with videos related to

Sort By:
Pageof 74
Journal of Musculoskeletal & Neuronal Interactions|December 1, 2010
Musculoskeletal symptoms and neurological investigations in adrenocortical insufficiency: a case report and literature reviewH Kinoshita, S Mizutani, K Sei, et al.
Journal of Neurochemistry|March 31, 1999
Developmental neurotoxicity of phenytoin on granule cells and Purkinje cells in mouse cerebellumH Ohmori, H Ogura, M Yasuda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 29, 1999
[The current status of molecular detection of micrometastatic prostate cancer cells]T Deguchi, M Yang, M Yasuda, et al.
Nihon Sanka Fujinka Gakkai Zasshi|September 1, 1994
[Assessment of osteoporosis in the local population by means of a portable dual energy X-ray absorptiometry unit]M Yasuda, T Kurabayashi, T Yahata, et al.
Archives of Neurology|January 29, 1999
A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2M Yasuda, K Maeda, M Hashimoto, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Two novel oleanolic acid saponins having a sialyl Lewis X mimetic structure from Achyranthes fauriei rootY Ida, Y Satoh, M Katsumata, et al.
Nihon Sanka Fujinka Gakkai Zasshi|July 1, 1985
[A study on factors influencing survival in stage I ovarian cancer]M Yasuda, Y Nakabayashi, S Isonishi, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 1, 1988
[A case report of a family with serum cholinesterase deficiency]O Ikami, M Hamada, T Aoki, et al.
Clinical and Experimental Immunology|July 25, 2020
Serum level of soluble urokinase plasminogen activator receptor (suPAR) as a disease severity marker of myasthenia gravis: a pilot studyA Uzawa, Y Kojima, Y Ozawa, et al.
The American Journal of Cardiology|November 15, 1986
Effect of exercise on circulating atrial natriuretic polypeptide in valvular heart diseaseT Nishikimi, M Kohno, T Matsuura, et al.
Pageof 74